Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)
Keywords: سرطان سلول کوچک ریه; Small cell lung cancer; Proteasome inhibition; Bortezomib; Bcl-2;